• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重疲劳和记忆障碍与新冠后症状患者血清抗SARS-CoV-2抗体水平较低有关。

Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms.

作者信息

Molnar Tihamer, Varnai Reka, Schranz Daniel, Zavori Laszlo, Peterfi Zoltan, Sipos David, Tőkés-Füzesi Margit, Illes Zsolt, Buki Andras, Csecsei Peter

机构信息

Department of Anaesthesiology and Intensive Care, University of Pecs, Medical School, H7632 Pecs, Hungary.

Department of Primary Health Care, University of Pecs, Medical School, H7632 Pecs, Hungary.

出版信息

J Clin Med. 2021 Sep 23;10(19):4337. doi: 10.3390/jcm10194337.

DOI:10.3390/jcm10194337
PMID:34640355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8509483/
Abstract

BACKGROUND

Post-COVID manifestation is defined as persistent symptoms or long-term complications beyond 4 weeks from disease onset. Fatigue and memory impairment are common post-COVID symptoms. We aimed to explore associations between the timeline and severity of post-COVID fatigue and anti-SARS-CoV-2 antibodies.

METHODS

Fatigue and memory impairment were assessed in a total of 101 post-COVID subjects using the Chalder fatigue scale (CFQ-11) and a visual analogue scale. Using the bimodal scoring system generated from CFQ-11, a score ≥4 was defined as severe fatigue. Serum anti-SARS-CoV-2 spike (anti-S-Ig) and nucleocapsid (anti-NC-Ig) antibodies were examined at two time points: 4-12 weeks after onset of symptoms, and beyond 12 weeks.

RESULTS

The serum level of anti-S-Ig was significantly higher in patients with non-severe fatigue compared to those with severe fatigue at 4-12 weeks ( = 0.006) and beyond 12 weeks ( = 0.016). The serum level of anti-NC-Ig remained high in patients with non-severe fatigue at both time points. In contrast, anti-NC-Ig decreased significantly in severe fatigue cases regardless of the elapsed time (4-12 weeks: = 0.024; beyond 12 weeks: = 0.005). The incidence of memory impairment was significantly correlated with lower anti-S-Ig levels (-0.359, < 0.001).

CONCLUSION

The systemic immune response reflected by antibodies to SARS-CoV-2 is strongly correlated with the severity of post-COVID fatigue.

摘要

背景

新冠后症状被定义为疾病发作4周后持续存在的症状或长期并发症。疲劳和记忆障碍是常见的新冠后症状。我们旨在探讨新冠后疲劳的时间线和严重程度与抗SARS-CoV-2抗体之间的关联。

方法

使用查尔德疲劳量表(CFQ-11)和视觉模拟量表对总共101名新冠后患者的疲劳和记忆障碍进行评估。使用由CFQ-11生成的双峰评分系统,得分≥4被定义为严重疲劳。在两个时间点检测血清抗SARS-CoV-2刺突(抗S-Ig)和核衣壳(抗NC-Ig)抗体:症状出现后4-12周,以及12周后。

结果

在4-12周(P = 0.006)和12周后(P = 0.016),非严重疲劳患者的抗S-Ig血清水平显著高于严重疲劳患者。在两个时间点,非严重疲劳患者的抗NC-Ig血清水平均保持较高。相比之下,无论时间过去多久(4-12周:P = 0.024;12周后:P = 0.005),严重疲劳病例中的抗NC-Ig均显著下降。记忆障碍的发生率与较低的抗S-Ig水平显著相关(-0.359,P < 0.001)。

结论

SARS-CoV-2抗体反映的全身免疫反应与新冠后疲劳的严重程度密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62c0/8509483/8eb36f6958f5/jcm-10-04337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62c0/8509483/c82af3361836/jcm-10-04337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62c0/8509483/8eb36f6958f5/jcm-10-04337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62c0/8509483/c82af3361836/jcm-10-04337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62c0/8509483/8eb36f6958f5/jcm-10-04337-g002.jpg

相似文献

1
Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms.严重疲劳和记忆障碍与新冠后症状患者血清抗SARS-CoV-2抗体水平较低有关。
J Clin Med. 2021 Sep 23;10(19):4337. doi: 10.3390/jcm10194337.
2
Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms.抗核衣壳蛋白的血清水平而非抗刺突抗体的血清水平与长期新冠症状的改善相关。
Vaccines (Basel). 2022 Jan 21;10(2):165. doi: 10.3390/vaccines10020165.
3
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.COVID-19 恢复期患者体内 SARS-CoV-2 抗体动态变化和 B 细胞记忆应答特征。
Clin Microbiol Infect. 2021 Sep;27(9):1349.e1-1349.e6. doi: 10.1016/j.cmi.2021.05.008. Epub 2021 May 8.
4
Comparative evaluation of SARS-CoV-2 IgG assays against nucleocapsid and spike antigens.SARS-CoV-2 IgG 检测试剂盒(针对核衣壳蛋白和刺突蛋白)的比较评估。
Hum Antibodies. 2021;29(2):109-113. doi: 10.3233/HAB-210440.
5
Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects.康复的 COVID-19 患者体内抗 SARS-CoV-2 抗体的特征。
Viruses. 2021 Apr 16;13(4):697. doi: 10.3390/v13040697.
6
Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19.评估 COVID-19 住院患者的肌肉骨骼疼痛、疲劳和握力。
Eur J Phys Rehabil Med. 2021 Aug;57(4):653-662. doi: 10.23736/S1973-9087.20.06563-6. Epub 2021 Jan 4.
7
SARS-CoV-2 Antibodies and Associated Factors at Different Hospitalization Time Points in 192 COVID-19 Cases.192 例 COVID-19 患者不同住院时间点的 SARS-CoV-2 抗体及相关因素。
J Appl Lab Med. 2021 Sep 1;6(5):1133-1142. doi: 10.1093/jalm/jfab003.
8
Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer.针对 COVID-19 疫苗接种者和未接种者的严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)抗体:来自同一制造商的两种不同商业可用血清学检测方法的比较方法。
Clin Chim Acta. 2021 Jul;518:9-16. doi: 10.1016/j.cca.2021.03.007. Epub 2021 Mar 17.
9
Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.针对 SARS-CoV-2 刺突受体结合域和核衣壳的异源抗体及其对 COVID-19 免疫的影响。
JCI Insight. 2020 Sep 17;5(18):142386. doi: 10.1172/jci.insight.142386.
10
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.在 COVID-19 和恢复期,针对 SARS-CoV-2 刺突和核衣壳蛋白快速产生持久的 B 细胞记忆。
Sci Immunol. 2020 Dec 22;5(54). doi: 10.1126/sciimmunol.abf8891.

引用本文的文献

1
A multinational cross-sectional study on the prevalence and predictors of long COVID across 33 countries.一项关于33个国家中长新冠的患病率及预测因素的跨国横断面研究。
Sci Rep. 2025 Aug 3;15(1):28299. doi: 10.1038/s41598-025-10120-z.
2
Defining and measuring long COVID fatigue: a scoping review.定义和测量新冠后疲劳:一项范围综述
BMJ Open. 2024 Dec 11;14(12):e088530. doi: 10.1136/bmjopen-2024-088530.
3
Novel biomarkers of mitochondrial dysfunction in Long COVID patients.长期新冠患者线粒体功能障碍的新型生物标志物。

本文引用的文献

1
Long covid-mechanisms, risk factors, and management.长新冠的发病机制、危险因素和管理。
BMJ. 2021 Jul 26;374:n1648. doi: 10.1136/bmj.n1648.
2
Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh.新冠后综合征在有症状的 COVID-19 患者中的表现:孟加拉国一家三级保健中心的前瞻性队列研究。
PLoS One. 2021 Apr 8;16(4):e0249644. doi: 10.1371/journal.pone.0249644. eCollection 2021.
3
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study.
Geroscience. 2025 Apr;47(2):2245-2261. doi: 10.1007/s11357-024-01398-4. Epub 2024 Nov 4.
4
The multifaceted effects of migraine on Syrian society: insights from a multicenter cross-sectional study.偏头痛对叙利亚社会的多方面影响:一项多中心横断面研究的启示。
BMC Neurol. 2024 Nov 1;24(1):425. doi: 10.1186/s12883-024-03931-6.
5
Long Neuro-COVID-19: Current Mechanistic Views and Therapeutic Perspectives.长新冠:当前的发病机制观点和治疗展望。
Biomolecules. 2024 Aug 28;14(9):1081. doi: 10.3390/biom14091081.
6
Changes in Working Situations of Employed Long COVID Patients: Retrospective Study in Japanese Outpatient Clinic.长期新冠患者就业状况的变化:日本门诊诊所的回顾性研究
J Clin Med. 2024 Jun 28;13(13):3809. doi: 10.3390/jcm13133809.
7
Impact of Circulating Anti-Spike Protein Antibody Levels on Multi-Organ Long COVID Symptoms.循环抗刺突蛋白抗体水平对多器官长期新冠症状的影响
Vaccines (Basel). 2024 Jun 3;12(6):610. doi: 10.3390/vaccines12060610.
8
Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study.临床和血清学预测因素与新冠病毒感染后疾病的关系:来自加拿大前瞻性队列研究的结果。
Front Public Health. 2024 May 9;12:1276391. doi: 10.3389/fpubh.2024.1276391. eCollection 2024.
9
Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches.长新冠中的线粒体功能障碍:机制、后果和潜在治疗方法。
Geroscience. 2024 Oct;46(5):5267-5286. doi: 10.1007/s11357-024-01165-5. Epub 2024 Apr 26.
10
The Association between Dysnatraemia during Hospitalisation and Post-COVID-19 Mental Fatigue.住院期间低钠血症与新冠后精神疲劳之间的关联
J Clin Med. 2023 May 26;12(11):3702. doi: 10.3390/jcm12113702.
SARS-CoV-2 中和抗体反应动力学和免疫持久性:一项纵向研究。
Lancet Microbe. 2021 Jun;2(6):e240-e249. doi: 10.1016/S2666-5247(21)00025-2. Epub 2021 Mar 23.
4
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders.SARS-CoV-2 介导的神经炎症与 COVID-19 在神经退行性疾病中的作用。
Cytokine Growth Factor Rev. 2021 Apr;58:1-15. doi: 10.1016/j.cytogfr.2021.02.002. Epub 2021 Feb 19.
5
SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike.SARS-CoV-2 感染严重程度与针对刺突蛋白的体液免疫优势相关。
mBio. 2021 Jan 19;12(1):e02940-20. doi: 10.1128/mBio.02940-20.
6
NICE guideline on long COVID.英国国家卫生与临床优化研究所关于长期新冠的指南。
Lancet Respir Med. 2021 Feb;9(2):129. doi: 10.1016/S2213-2600(21)00031-X. Epub 2021 Jan 13.
7
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study.新冠病毒感染后综合征。发生率和危险因素:一项地中海队列研究。
J Infect. 2021 Mar;82(3):378-383. doi: 10.1016/j.jinf.2021.01.004. Epub 2021 Jan 12.
8
Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study.住院患者康复期血浆捐献者的抗SARS-CoV-2抗体反应增强;一项2期临床研究的亚组分析
Microorganisms. 2020 Nov 28;8(12):1885. doi: 10.3390/microorganisms8121885.
9
A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective.COVID-19 对人类生殖生物学、辅助生殖护理和妊娠影响的综合综述:加拿大视角。
J Ovarian Res. 2020 Nov 27;13(1):140. doi: 10.1186/s13048-020-00737-1.
10
Multi-omics examination of Q fever fatigue syndrome identifies similarities with chronic fatigue syndrome.Q热疲劳综合征的多组学研究揭示了其与慢性疲劳综合征的相似之处。
J Transl Med. 2020 Nov 26;18(1):448. doi: 10.1186/s12967-020-02585-5.